Back to Article
Bioinformatic Analysis of GCN1 as a Novel Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma and Preliminary Exploration of Its Molecular Mechanisms
World Journal of Cancer and Oncology Research
| Vol 4, Issue 1
Table 1. Baseline Characteristics
| Characteristics | overall |
| Pathologic T stage, n (%) | |
| T1 | 101 (61.6%) |
| T2&T3&T4 | 63 (38.4%) |
| Pathologic N stage, n (%) | |
| N0 | 163 (99.4%) |
| N1 | 1 (0.6%) |
| Pathologic M stage, n (%) | |
| M0 | 161 (98.2%) |
| M1 | 3 (1.8%) |
| Gender, n (%) | |
| Male | 110 (67.1%) |
| Female | 54 (32.9%) |
| Age, n (%) | |
| <= 60 | 91 (55.5%) |
| > 60 | 73 (44.5%) |
| BMI, n (%) | |
| <= 25 | 95 (57.9%) |
| > 25 | 69 (42.1%) |
| AFP (ng/ml), n (%) | |
| <= 400 | 123 (75%) |
| > 400 | 41 (25%) |
| Albumin(g/dl), n (%) | |
| < 3.5 | 36 (22%) |
| >= 3.5 | 128 (78%) |
| Prothrombin time, n (%) | |
| <= 4 | 130 (79.3%) |
| > 4 | 34 (20.7%) |
| Vascular invasion, n (%) | |
| No | 111 (67.7%) |
| Yes | 53 (32.3%) |